Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 333 of 6351
-
New hope for HIV patients: shorter, stronger fungal infection treatment on trial
Disease control Not yet recruitingLAmB-FAST is a factorial randomized controlled trial simultaneously testing two interventions in one trial. LAmB-FAST seeks to inform treatment guidelines on the induction and maintenance therapy of HIV-associated talaromycosis (formerly called penicilliosis) and will answer the …
Phase 3 • Sponsor: Duke University • Aim: Disease control
Last updated Aug 29, 2026 00:00 UTC
-
New hope for tough leukemia: precision drug combo trial launches
Disease control Not yet recruitingTo evaluate the benefit of a precision medicine based strategy (targeted therapeutic options (TTOs)) for patients with relapsed/refractory T-cell acute lymphoblastic leukemia (T-ALL) (in terms of composite remission).
Phase 2 • Sponsor: Philippe ROUSSELOT • Aim: Disease control
Last updated Jun 27, 2026 12:09 UTC
-
New urine test aims to catch aggressive prostate cancer early
Diagnosis Not yet recruitingThis clinical trial tests how well a urine prostate cancer screening test, My Prostate Score 2 (MPS2), integrated with magnetic resonance imaging (MRI) works for early detection of prostate cancer. MPS2 is an investigational urine-based test designed to help identify the likeliho…
Sponsor: University of Michigan Rogel Cancer Center • Aim: Diagnosis
Last updated Jun 27, 2026 13:05 UTC
-
New hope for bipolar depression? pramipexole trial targets anhedonia
Symptom relief Not yet recruitingAmong psychiatric disorders, bipolar disorder stands out due to its alarmingly high suicide rates. This condition presents unique management challenges, especially during its depressive phase, which carries the highest risk of suicide. B-HAPPI is an academic randomized controlled…
Phase 3 • Sponsor: Daniel Lindqvist • Aim: Symptom relief
Last updated Jul 03, 2026 00:00 UTC
-
Could light therapy ease Chemo's nerve pain?
Symptom relief Not yet recruitingChemotherapy-induced peripheral neuropathy (CIPN) is one of the common complications of cancer treatment and involves paresthesia, numbness and/or burning pain in distal limbs. This condition has a high health impact because it is associated with psychological distress, fall risk…
Sponsor: Jules Bordet Institute • Aim: Symptom relief
Last updated Jul 04, 2026 00:00 UTC
-
New oral drug aims to tame ulcerative colitis Flare-Ups
Disease control Recruiting nowA multicenter, randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of Ponesimod (VSP-128) in patients with moderately to severely active ulcerative colitis
Phase 3 • Sponsor: Vanda Pharmaceuticals • Aim: Disease control
Last updated Aug 20, 2026 00:00 UTC
-
AI takes the wheel: could a computer outthink doctors on ventilator settings for kids?
Disease control Not yet recruitingThis prospective, randomized controlled trial aims to evaluate whether an AI-driven decision support system can improve clinical outcomes for mechanically ventilated pediatric patients (aged 1 month to 18 years) in the PICU, compared to standard care. The primary question address…
Sponsor: Wu Rongzhou • Aim: Disease control
Last updated Jul 29, 2026 00:00 UTC
-
Could an antifungal pill guard the kidneys during heart surgery?
Prevention Not yet recruitingPrimary Objective: To evaluate the efficacy and safety of perioperative oral terbinafine in reducing the incidence of cardiac surgery-associated acute kidney injury (CSA-AKI).Secondary Objectives:To assess the effects of terbinafine on the severity of post-cardiac surgery AKI, le…
Phase 2 • Sponsor: Guangdong Provincial People's Hospital • Aim: Prevention
Last updated Aug 02, 2026 00:00 UTC
-
Can a detailed map of pain nerves unlock new chronic pain treatments?
Knowledge-focused Not yet recruitingThis study aims to improve our understanding of how the nerves that detect and transmit pain signals work in humans. Chronic pain affects millions of people worldwide and can be difficult to treat because the biological mechanisms underlying pain are not yet fully understood. By …
Sponsor: King's College Hospital NHS Trust • Aim: Knowledge-focused
Last updated Aug 02, 2026 00:00 UTC
-
Can virtual reality help women overcome vaginismus?
Symptom relief Not yet recruitingVaginismus, a condition characterized by involuntary tightening of the pelvic floor muscles due to strong fear of vaginal insertion, impact ≥6% of the female population and can make vaginal intercourse and medical exams difficult. This project explores virtual reality exposure (V…
Sponsor: University of British Columbia • Aim: Symptom relief
Last updated Aug 07, 2026 00:00 UTC
-
Could a simple fat swap reshape your gut bacteria and protect your heart?
Knowledge-focused Not yet recruitingStearic acid and palmitic acid are two common consumed saturated fatty acids found in foods. Palmitic acid is associated with increases in blood cholesterol, whereas stearic acid is generally considered neutral with respect to blood cholesterol. However, the mechanisms underlying…
Sponsor: Tufts University • Aim: Knowledge-focused
Last updated Aug 19, 2026 00:00 UTC
-
Double acupuncture approach may tackle obesity
Disease control Not yet recruitingAcupoint catgut embedding and laser acupuncture have each been studied as treatments for obesity in adults, but the two have not been evaluated in combination, and few trials have measured anthropometric, biochemical, and blood pressure outcomes together. This single-center rand…
Sponsor: Taipei City Hospital • Aim: Disease control
Last updated Aug 20, 2026 00:00 UTC
-
Can a new injection tame the toxic ammonia of urea cycle disorders?
Disease control Not yet recruitingPhase 1/2 Study of KRRO-121 is a randomized, placebo-controlled study in Healthy Volunteers (Phase 1 SAD and MAD) and Study Participants with Urea Cycle Disorders (Phase 2). The primary objective of the study is to evaluate the safety of KRRO-121.
Phase 1/2 • Sponsor: Korro Bio, Inc. • Aim: Disease control
Last updated Aug 22, 2026 00:00 UTC
-
A new twist on lung rehab: helping the helpers
Disease control Not yet recruitingChronic respiratory diseases are leading causes of death and disability worldwide, imposing an enormous burden on individuals, families, and societies. Dependence on others begins early in the disease course. Over 70% of people with a chronic respiratory disease rely on informal …
Sponsor: Aveiro University • Aim: Disease control
Last updated Aug 29, 2026 00:00 UTC
-
Can a triple laser combo turn back sun damage and ward off skin cancer?
Prevention Recruiting nowThe Multimodal Laser Project is a prospective, randomized, split-face clinical study investigating a novel combination of laser and light-based treatments for facial photodamage with the long-term perspective of improving skin cancer prevention. The study includes 35 patients wi…
Sponsor: Merete Haedersdal • Aim: Prevention
Last updated Sep 10, 2026 03:00 UTC
-
Can talk therapy help men at HIV risk embrace PrEP?
Prevention Not yet recruitingThe purpose of this research study is to adapt, implement, and evaluate a 10-session mental health intervention with men who have sex with men at the Regional AIDS Interfaith Network to find out if it will reduce anxiety and depression and increase awareness and use of pre-exposu…
Sponsor: Wake Forest University Health Sciences • Aim: Prevention
Last updated Aug 30, 2026 00:00 UTC
-
Can a Two-Drug cream clear precancerous skin spots even when immunity is suppressed?
Disease control Not yet recruitingCombination field therapy with 5-fluorouracil and calcipotriene (5FU/C) has become standard of care among dermatologists for the field treatment of diffuse actinic keratoses (AKs). Data suggest that the addition of calcipotriene elicits a sustained T cell memory allowing for both…
Sponsor: Cedars-Sinai Medical Center • Aim: Disease control
Last updated Sep 02, 2026 00:00 UTC
-
Can a 20-Minute brain zap ease depression in pregnancy?
Symptom relief Not yet recruitingThe purpose of this pilot trial is to primarily assess safety, feasibility, and tolerability of PandA-tACS in antenatal depression and determine whether a single PandA-tACS session produces greater left dlPFC aperiodic slope flattening (reduction) from pre- to post-stimulation th…
Sponsor: University of North Carolina, Chapel Hill • Aim: Symptom relief
Last updated Sep 04, 2026 00:00 UTC
-
Can a smaller stent tame brain fog after liver shunt surgery?
Disease control Recruiting nowRefractory hepatic encephalopathy (RHE) after transjugular intrahepatic portosystemic shunt (TIPS) is a serious complication that can markedly impair quality of life and worsen prognosis. Standard medical management-including lactulose, rifaximin, nutritional support, and correct…
Sponsor: Air Force Military Medical University, China • Aim: Disease control
Last updated Sep 04, 2026 00:00 UTC
-
Can a 15-Day wearable sensor keep blood sugar on target?
Disease control Not yet recruitingThis clinical study evaluates the GX-01S Continuous Glucose Monitoring (CGM) System in adults with Type 1 or Type 2 diabetes. CGM systems measure glucose levels continuously throughout the day, providing real-time information that can help patients manage their diabetes more effe…
Sponsor: MicroTech Medical(Hangzhou)Co.,Ltd. • Aim: Disease control
Last updated Sep 10, 2026 03:00 UTC